Rockland Immunochemicals Awarded Phase I SBIR Funding

News   Oct 22, 2013

 
Rockland Immunochemicals Awarded Phase I SBIR Funding
 
 
 

RELATED ARTICLES

Feisty Fetal T Cells Can Rebel In Utero

News

Preterm labor, a common pregnancy complication, has long been a mystery to scientists. But a new study shows it may sometimes happen when the fetal immune system “wakes up” too early and begins to reject the mother, causing the uterus to start contracting.

READ MORE

Investigating Inflammasomes Implicated in Diabetic Retinopathy

News

Team of researchers employ mouse model exhibiting diabetic retinopathy symptoms that could lead to future translational research studies.

READ MORE

“Lymphoma Micro-reactor” Targets Chemo-Resistant Lymphoma

News

Researchers have developed a “lymphoma micro-reactor” device that exposes human lymphomas to fluid flow similar to that in the lymphatics and parts of the lymph node.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE